TYZEKA(TM) (telbivudine) Approved By U.S. Food And Drug Administration (FDA) As A New Treatment For Patients With (Medical News Today)
Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) today announced the approval of TYZEKA(TM) (telbivudine) by the U.S. Food and Drug Administration (FDA) as a new once-a-day oral treatment, taken with or without food, for patients with chronic hepatitis B (CHB). [click link for full article]

Patient Recruitment to Resume Without Modification of Protocol for Desmoteplase Phase IIB/III Stroke Study DIAS-2 (PR Newswire via Yahoo! Finance)
Forest Laboratories, Inc. and its development partner for desmoteplase, PAION AG , today announced that the independent Data Monitoring Committee for the DIAS-2 Phase IIB/III study met and informed the Steering Committee and the Companies that it has reviewed the cumulative data from the study provided by the Companies and recommended the resumption of patient enrollment into DIAS-2 with no

Protein Polymer Technologies Receives FDA 510(K) Clearance of New Indication for Embolization Convenience Kits (RedNova)
Protein Polymer Technologies, Inc. (OTCBB: PPTI), a biotechnology device company that is a pioneer in protein design and synthesis, today announced that it has received 510(k) clearance from the U.S.